Figure 3.

(A) Mean number (standard deviation [SD]) of bevacizumab injections over 12 months, by diagnosis group and cohort; (B) mean number (SD) of bevacizumab injections over 6 months, by diagnosis group and cohort.

Notes: *One-way analysis of variance comparing mean time across cohorts. In each diagnosis group, the mean number of injections administered over the 12-month period after the first injection (index date) increased, with mean differences across the cohorts being statistically significant in the BRVO and DME groups, but not in the CRVO group.

Abbreviations: BRVO, branch retinal vein occlusion; CRVO, central retinal vein occlusion; DME, diabetic macular edema.